-
公开(公告)号：US20130157978A1
公开(公告)日：2013-06-20
申请号：US13767730
申请日：2013-02-14
申请人： N.V. Nutricia
IPC分类号： A61K31/685 , A61K31/4415 , A61K31/202 , A61K31/14 , A61K31/355 , A61K31/683 , A61K31/205 , A61K31/519 , A61K31/194
CPC分类号： A61K31/685 , A23L33/105 , A23L33/115 , A23L33/15 , A23L33/16 , A23V2002/00 , A61K31/14 , A61K31/194 , A61K31/20 , A61K31/202 , A61K31/205 , A61K31/355 , A61K31/4415 , A61K31/519 , A61K31/683 , A61K33/30 , A61K33/34 , A61K36/16 , A61K45/06 , A61K2300/00 , A23V2250/1842 , A23V2250/7052 , A23V2250/706 , A23V2250/161 , A23V2250/1642 , A23V2250/032 , A23V2250/1846 , A23V2250/1852 , A23V2250/1848 , A23V2250/156 , A23V2250/5114 , A23V2250/704 , A23V2250/716
摘要： The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions: fraction a) consisting of long chain polyunsaturated fatty acids; fraction b) consisting of phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine. fraction c) consisting of compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.
摘要翻译： 本发明涉及适用于预防和/或治疗血管疾病的制剂，其包含以下级分：级分a）由长链多不饱和脂肪酸组成; 组分b）由磷脂组成，该级分含有至少两种选自磷脂酰丝氨酸，磷脂酰肌醇，磷脂酰胆碱和磷脂酰乙醇胺的不同磷脂。 组分c）由作为甲硫氨酸代谢因子的化合物组成，该级分含有选自叶酸，维生素B12，维生素B6，镁和锌中的至少一种。
-
公开(公告)号：US20070202194A1
公开(公告)日：2007-08-30
申请号：US11741547
申请日：2007-04-27
申请人： Amanda Kiliaan , Robert Hageman
发明人： Amanda Kiliaan , Robert Hageman
IPC分类号： A61K33/34 , A61K31/495 , A61K31/535 , A61K33/30
CPC分类号： A61K31/685 , A23L33/105 , A23L33/115 , A23L33/15 , A23L33/16 , A23V2002/00 , A61K31/14 , A61K31/194 , A61K31/20 , A61K31/202 , A61K31/205 , A61K31/355 , A61K31/4415 , A61K31/519 , A61K31/683 , A61K33/30 , A61K33/34 , A61K36/16 , A61K45/06 , A61K2300/00 , A23V2250/1842 , A23V2250/7052 , A23V2250/706 , A23V2250/161 , A23V2250/1642 , A23V2250/032 , A23V2250/1846 , A23V2250/1852 , A23V2250/1848 , A23V2250/156 , A23V2250/5114 , A23V2250/704 , A23V2250/716
摘要： The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions: fraction a) consisting of long chain polyunsaturated fatty acids; fraction b) consisting of phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine. fraction c) consisting of compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.
摘要翻译： 本发明涉及适用于预防和/或治疗血管疾病的制剂，其包含以下级分：级分a）由长链多不饱和脂肪酸组成; 组分b）由磷脂组成，该级分含有至少两种选自磷脂酰丝氨酸，磷脂酰肌醇，磷脂酰胆碱和磷脂酰乙醇胺的不同磷脂。 组分c）由作为甲硫氨酸代谢因子的化合物组成，该级分含有选自叶酸，维生素B12，维生素B6，镁和锌中的至少一种。
-
公开(公告)号：US20080193561A1
公开(公告)日：2008-08-14
申请号：US12102754
申请日：2008-04-14
IPC分类号： A61K33/34 , A61K33/30 , A61K33/06 , A61K31/519 , A61K31/714 , A61K31/4415 , A61K31/4748
CPC分类号： A61K31/685 , A23L33/105 , A23L33/115 , A23L33/15 , A23L33/16 , A23V2002/00 , A61K31/14 , A61K31/194 , A61K31/20 , A61K31/202 , A61K31/205 , A61K31/355 , A61K31/4415 , A61K31/519 , A61K31/683 , A61K33/30 , A61K33/34 , A61K36/16 , A61K45/06 , A61K2300/00 , A23V2250/1842 , A23V2250/7052 , A23V2250/706 , A23V2250/161 , A23V2250/1642 , A23V2250/032 , A23V2250/1846 , A23V2250/1852 , A23V2250/1848 , A23V2250/156 , A23V2250/5114 , A23V2250/704 , A23V2250/716
摘要： The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions:fraction a) consisting of long chain polyunsaturated fatty acids;fraction b) consisting of phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine.fraction c) consisting of compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.
摘要翻译： 本发明涉及适用于预防和/或治疗血管疾病的制剂，其包含以下级分：级分a）由长链多不饱和脂肪酸组成; 组分b）由磷脂组成，该级分含有至少两种选自磷脂酰丝氨酸，磷脂酰肌醇，磷脂酰胆碱和磷脂酰乙醇胺的不同磷脂。 组分c）由作为甲硫氨酸代谢因子的化合物组成，该级分含有选自叶酸，维生素B12，维生素B6，镁和锌中的至少一种。
-
公开(公告)号：US20030143304A1
公开(公告)日：2003-07-31
申请号：US10275566
申请日：2002-11-07
IPC分类号： A23L001/30
CPC分类号： A23K20/10 , A23C9/158 , A23K20/174 , A23L2/52 , A23L33/15 , A23L33/30 , A23L33/40 , A23V2002/00 , C07D475/04 , A23V2250/5486 , A23V2250/716 , A23V2250/5482 , A23V2250/628 , A23V2250/616 , A23V2250/1578 , A23V2250/70 , A23V2250/702 , A23V2250/708 , A23V2250/71 , A23V2250/704 , A23V2250/032 , A23V2250/211
摘要： Compositions are proposed which comprise folic acid in combination with 5-methyltetrahydrofolic acid, and also compositions which comprise folic acid, 5-methyltetrahydrofolic acid and/or 5-methyltetrahydrofolylpolyglutamate and also comprise a dietary component and/or a nutrient preparation, and their use is also proposed.
摘要翻译： 提出了组合物，其包含与5-甲基四氢叶酸组合的叶酸，以及包含叶酸，5-甲基四氢叶酸和/或5-甲基四氢呋喃基聚谷氨酸盐并且还包含膳食组分和/或营养制剂的组合物，其用途是 也提出。
-
公开(公告)号：US07560447B2
公开(公告)日：2009-07-14
申请号：US11741547
申请日：2007-04-27
CPC分类号： A61K31/685 , A23L33/105 , A23L33/115 , A23L33/15 , A23L33/16 , A23V2002/00 , A61K31/14 , A61K31/194 , A61K31/20 , A61K31/202 , A61K31/205 , A61K31/355 , A61K31/4415 , A61K31/519 , A61K31/683 , A61K33/30 , A61K33/34 , A61K36/16 , A61K45/06 , A61K2300/00 , A23V2250/1842 , A23V2250/7052 , A23V2250/706 , A23V2250/161 , A23V2250/1642 , A23V2250/032 , A23V2250/1846 , A23V2250/1852 , A23V2250/1848 , A23V2250/156 , A23V2250/5114 , A23V2250/704 , A23V2250/716
摘要： The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions: fraction a) consisting of long chain polyunsaturated fatty acids; fraction b) consisting of phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine. fraction c) consisting of compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.
摘要翻译： 本发明涉及适用于预防和/或治疗血管疾病的制剂，其包含以下级分：级分a）由长链多不饱和脂肪酸组成; 组分b）由磷脂组成，该级分含有至少两种选自磷脂酰丝氨酸，磷脂酰肌醇，磷脂酰胆碱和磷脂酰乙醇胺的不同磷脂。 组分c）由作为甲硫氨酸代谢因子的化合物组成，该级分含有选自叶酸，维生素B12，维生素B6，镁和锌中的至少一种。
-
公开(公告)号：US06569857B1
公开(公告)日：2003-05-27
申请号：US09303689
申请日：1999-05-03
申请人： Marc S. Hermelin , R. Saul Levinson
发明人： Marc S. Hermelin , R. Saul Levinson
IPC分类号： A61K3150
CPC分类号： A61K33/06 , A23L33/12 , A23L33/15 , A23L33/40 , A23V2002/00 , A61K31/505 , A61K31/44 , A61K31/375 , A61K31/355 , A61K31/20 , A61K2300/00 , A23V2250/70 , A23V2250/1874 , A23V2250/1872 , A23V2250/1868 , A23V2250/1578 , A23V2250/1588 , A23V2250/1642 , A23V2250/716 , A23V2250/7052 , A23V2250/712 , A23V2250/156 , A23V2250/708 , A23V2250/161
摘要： The present disclosure relates to novel nutritional compositions and methods for augmenting the possibility of conception while increasing nutritional stores to aid development of healthy embryos and child growth. The nutritional compositions are intended for use by both males and females planning to conceive a child.
摘要翻译： 本公开涉及新颖的营养组合物和方法，用于增加受孕的可能性，同时增加营养储备以帮助健康胚胎和儿童生长的发育。 营养组合物由男性和女性计划用于怀孕的孩子使用。
-
公开(公告)号：US08865687B2
公开(公告)日：2014-10-21
申请号：US13767730
申请日：2013-02-14
申请人： N.V. Nutricia
IPC分类号： A61K31/60 , A61K31/20 , A61K36/15 , A61K31/205 , A23L1/30 , A61K45/06 , A61K31/519 , A61K36/16 , A61K33/30 , A61K31/685 , A61K31/4415 , A61K31/194 , A23L1/304 , A61K31/355 , A23L1/302 , A61K31/202 , A61K33/34 , A61K31/683 , A61K31/14
CPC分类号： A61K31/685 , A23L33/105 , A23L33/115 , A23L33/15 , A23L33/16 , A23V2002/00 , A61K31/14 , A61K31/194 , A61K31/20 , A61K31/202 , A61K31/205 , A61K31/355 , A61K31/4415 , A61K31/519 , A61K31/683 , A61K33/30 , A61K33/34 , A61K36/16 , A61K45/06 , A61K2300/00 , A23V2250/1842 , A23V2250/7052 , A23V2250/706 , A23V2250/161 , A23V2250/1642 , A23V2250/032 , A23V2250/1846 , A23V2250/1852 , A23V2250/1848 , A23V2250/156 , A23V2250/5114 , A23V2250/704 , A23V2250/716
摘要： The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions: fraction a) consisting of long chain polyunsaturated fatty acids; fraction b) consisting of phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine. fraction c) consisting of compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.
摘要翻译： 本发明涉及适用于预防和/或治疗血管疾病的制剂，其包含以下级分：级分a）由长链多不饱和脂肪酸组成; 组分b）由磷脂组成，该级分含有至少两种选自磷脂酰丝氨酸，磷脂酰肌醇，磷脂酰胆碱和磷脂酰乙醇胺的不同磷脂。 组分c）由作为甲硫氨酸代谢因子的化合物组成，该级分含有选自叶酸，维生素B12，维生素B6，镁和锌中的至少一种。
-
8.发明授权Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith 有权用于预防和/或治疗与其相关的血管疾病和继发性疾病的方法和制备公开(公告)号：US07208180B2
公开(公告)日：2007-04-24
申请号：US09899922
申请日：2001-07-09
IPC分类号： A61K36/00 , A61K36/38 , A61K36/16 , A61K36/752
CPC分类号： A61K45/06 , A23L33/105 , A23L33/115 , A23L33/15 , A23L33/16 , A23V2002/00 , A61K31/20 , A61K31/201 , A61K31/685 , A61K33/30 , A61K33/34 , A61K36/16 , A61K36/38 , A61K36/48 , A61K36/81 , Y10S514/822 , A61K2300/00 , A23V2250/1842 , A23V2250/7052 , A23V2250/706 , A23V2250/161 , A23V2250/1642 , A23V2250/032 , A23V2250/1846 , A23V2250/1852 , A23V2250/1848 , A23V2250/156 , A23V2250/5114 , A23V2250/704 , A23V2250/716
摘要： The present invention relates to a method for the prevention and/or treatment of vascular disorders and/or secondary disorders associated therewith, such as depression. The method according to the invention comprises the oral administration of a preparation which contains at least the following fractions: a) long chain polyunsaturated fatty acids; b) at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine and c) one or more compounds which are a factor in methionine metabolism, which compounds are selected from the group consisting of folate, vitamin B12, vitamin B6, magnesium and zinc or equivalents thereof. The invention also relates to a preparation for oral dosage comprising: at least 120 mg of long chain polyunsaturated fatty acids; at least 200 mg phospholipids; at least 200 μg folate; and at least 0.1 mg hypericin and/or at least 100 mg extract of Withania somnifera.
摘要翻译： 本发明涉及一种预防和/或治疗与其相关的血管疾病和/或继发性疾病如抑郁症的方法。 根据本发明的方法包括口服给药至少包含以下组分的制剂：a）长链多不饱和脂肪酸; b）至少两种选自磷脂酰丝氨酸，磷脂酰肌醇，磷脂酰胆碱和磷脂酰乙醇胺的磷脂，c）一种或多种作为蛋氨酸代谢因子的化合物，该化合物选自叶酸，维生素B12，维生素 B6，镁和锌或其等同物。 本发明还涉及口服剂量的制剂，其包含：至少120mg长链多不饱和脂肪酸; 至少200mg磷脂; 至少200杯茶叶; 和至少0.1mg金丝桃素和/或至少100毫克的隐孢子虫提取物。
-
公开(公告)号：US06500472B2
公开(公告)日：2002-12-31
申请号：US09794176
申请日：2001-02-27
IPC分类号： A23L1302
CPC分类号： C07K14/79 , A23L33/15 , A23V2002/00 , A23V2250/54248 , Y10S514/904 , Y10S514/905 , A23V2250/716 , A23V2250/706 , A23V2250/154 , A23V2250/628 , A23V2250/21 , A23V2250/032 , A23V2250/1614 , A23V2250/6412 , A23V2250/6416 , A23V2250/2482 , A23V2250/636
摘要： Folic acid and/or vitamin B12 and lactoferrin are mixed to produce a folic acid and/or vitamin B12-lactoferrin complex. The complex can be used for enriching foods or drink.
摘要翻译： 将叶酸和/或维生素B12和乳铁蛋白混合以产生叶酸和/或维生素B12-乳铁蛋白复合物。 该复合物可用于丰富食物或饮料。
-
公开(公告)号：US20010036500A1
公开(公告)日：2001-11-01
申请号：US09794176
申请日：2001-02-27
IPC分类号： A23L001/30
CPC分类号： C07K14/79 , A23L33/15 , A23V2002/00 , A23V2250/54248 , Y10S514/904 , Y10S514/905 , A23V2250/716 , A23V2250/706 , A23V2250/154 , A23V2250/628 , A23V2250/21 , A23V2250/032 , A23V2250/1614 , A23V2250/6412 , A23V2250/6416 , A23V2250/2482 , A23V2250/636
摘要： Folic acid and/or vitamin B12 and lactoferrin are mixed to produce a folic acid and/or vitamin B12-lactoferrin complex. The complex can be used for enriching foods or drink.
摘要翻译： 将叶酸和/或维生素B12和乳铁蛋白混合以产生叶酸和/或维生素B12-乳铁蛋白复合物。 该复合物可用于丰富食物或饮料。
-
-
-
-
-
-
-
-
-
搜索结果
16 条记录 (耗时 0.012 秒)
